Literature DB >> 17932810

Oral cancer proteomics.

Shen Hu1, David T Wong.   

Abstract

Proteomics is a novel molecular profiling technology that may significantly accelerate human cancer research. This review summarizes recent progress in oral cancer proteomics and discusses potential applications in this emerging field. With the rapid development of proteomics tools, this technology platform will be utilized to discover highly sensitive and specific protein markers for cancer diagnosis and prognosis, elucidate the molecular determinants and key signal pathways underlying the disease mechanism, identify novel therapeutic targets and assess drug efficacy and toxicity, and to monitor treatment response and the relapse of the cancer. These proteomic applications may collectively facilitate the early detection and successful treatment of this devastating disease in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932810

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  9 in total

Review 1.  Salivary biomarkers for clinical applications.

Authors:  Lei Zhang; Hua Xiao; David T Wong
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 2.  Emerging horizons of salivary diagnostics for periodontal disease.

Authors:  L Fuentes; M Yakob; D T W Wong
Journal:  Br Dent J       Date:  2014-11       Impact factor: 1.626

3.  Quantification of Serum Proteins of Metastatic Oral Cancer Patients Using LC-MS/MS and iTRAQ Labeling.

Authors:  Lifeng Zhang; Jiang Jiang; Martha Arellano; Lei Zhang; Xinmin Yan; David T Wong; Shen Hu
Journal:  Open Proteomics J       Date:  2008

4.  Cytokines in saliva increase in head and neck cancer patients after treatment.

Authors:  Nickole Russo; Emily Bellile; Carol Anne Murdoch-Kinch; Min Liu; Avi Eisbruch; Greg T Wolf; Nisha J D'Silva
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-06-09

5.  Salivary biomarkers in the diagnosis of periodontal diseases.

Authors:  Jeffrey J Kim; Christine J Kim; Paulo M Camargo
Journal:  J Calif Dent Assoc       Date:  2013-02

6.  Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro.

Authors:  Chang S Lau; David T W Wong
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

7.  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.

Authors:  Anna Farnedi; Silvia Rossi; Nicoletta Bertani; Mariolina Gulli; Enrico Maria Silini; Maria Teresa Mucignat; Tito Poli; Enrico Sesenna; Davide Lanfranco; Lucio Montebugnoli; Elisa Leonardi; Claudio Marchetti; Renato Cocchi; Andrea Ambrosini-Spaltro; Maria Pia Foschini; Roberto Perris
Journal:  BMC Cancer       Date:  2015-05-03       Impact factor: 4.430

8.  Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients.

Authors:  Sara Principe; Enrique Zapater-Latorre; Leo Arribas; Enrique Garcia-Miragall; Jose Bagan
Journal:  Clin Oral Investig       Date:  2021-07-12       Impact factor: 3.606

9.  Protein expression analysis of inflammation-related colon carcinogenesis.

Authors:  Yumiko Yasui; Takuji Tanaka
Journal:  J Carcinog       Date:  2009
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.